Drug:
Reaction: ERYTHEMA
20250101 - 20251231
No. 201 - 300
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 201 | 25114476 |
US |
74 | 2 |
Erythema, Feeling hot, |
||||
NIVOLUMAB, PEMETREXED, PEMETREXED DISODIUM, CISPLATIN, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, |
||||
| 202 | 25114499 |
US |
31 | 1 |
Eczema, Erythema, Pruritus, Exfoliative rash, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
| 203 | 25114644 |
GB |
52 | 2 |
Acral peeling skin syndrome, Erythema, Skin burning sensation, Pseudofolliculitis, Pruritus, Pain, Medication error, |
||||
| 204 | 25114960 |
JP |
5 | 2 |
Erythema, Neutrophil count decreased, |
||||
PEMBROLIZUMAB, |
||||
| 205 | 25114993 |
ES |
62 | 2 |
Infusion related reaction, Dizziness, Erythema, |
||||
PACLITAXEL, |
||||
| 206 | 25115240 |
US |
49 | 1 |
Dermatitis atopic, Skin swelling, Dry skin, Erythema, Pruritus, |
||||
DUPILUMAB, |
||||
| 207 | 25115378 |
CN |
31 | |
Erythema, |
||||
CISATRACURIUM BESYLATE, |
||||
| 208 | 25115413 |
CN |
57 | 2 |
Anaphylactic shock, Hypoaesthesia, Hypoaesthesia oral, Pruritus, Skin temperature increased, Erythema, Tremor, Musculoskeletal stiffness, Pallor, Confusional state, Blood pressure decreased, Foaming at mouth, Loss of consciousness, Unresponsive to stimuli, Urinary incontinence, Anal incontinence, Cold sweat, Heart rate decreased, Respiratory rate increased, |
||||
IOPROMIDE, |
||||
| 209 | 25109200 |
US |
45 | 1 |
Rash macular, Erythema, Dry skin, Pruritus, Skin burning sensation, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 210 | 25109338 |
US |
18 | 1 |
Eczema, Erythema, Dry skin, Therapeutic response shortened, |
||||
DUPILUMAB, |
||||
| 211 | 25109399 |
US |
2 | |
Eczema, Dry skin, Erythema, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 212 | 25107746 |
US |
49 | 2 |
Dry skin, Pain of skin, Erythema, |
||||
DUPILUMAB, |
||||
| 213 | 25107845 |
US |
48 | 2 |
Pruritus, Erythema, Sleep disorder due to a general medical condition, Skin atrophy, Sticky skin, Pain in extremity, |
||||
DUPILUMAB, |
||||
| 214 | 25107907 |
US |
30 | 2 |
Pain in extremity, Loss of personal independence in daily activities, Erythema, Injection site erythema, Injection site swelling, Injection site pain, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 215 | 25107936 |
US |
12 | 2 |
Dry skin, Erythema, Rash, Dry eye, |
||||
DUPILUMAB, |
||||
| 216 | 25107938 |
US |
7 | 2 |
Erythema, Erythema of eyelid, |
||||
DUPILUMAB, |
||||
| 217 | 25107982 |
US |
24 | 2 |
Erythema, |
||||
DUPILUMAB, |
||||
| 218 | 25107990 |
US |
38 | 2 |
Injection site irritation, Injection site rash, Erythema, |
||||
DUPILUMAB, |
||||
| 219 | 25108004 |
US |
1 | 1 |
Rash pruritic, Erythema, |
||||
DUPILUMAB, |
||||
| 220 | 25108006 |
US |
44 | 1 |
Malaise, Diarrhoea, Eczema, Rash papular, Erythema, Pruritus, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 221 | 25108041 |
US |
2 | |
Rash, Erythema, Pruritus, |
||||
DUPILUMAB, DOXYCYCLINE HYCLATE, SPIRONOLACTONE, ZINC, ZINC GLUCONATE, ZINC CHLORIDE, |
||||
| 222 | 25108134 |
US |
17 | 2 |
Erythema, Erythema of eyelid, Dry eye, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 223 | 25108201 |
US |
3 | 2 |
Erythema, Eye pruritus, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 224 | 25108515 |
FR |
67 | 1 |
Eosinopenia, Erythema, |
||||
HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE, CEFEPIME HYDROCHLORIDE, CEFEPIME, CEFEPIME HYDROCHLORIDE, CEFEPIME, |
||||
| 225 | 25108594 |
US |
2 | |
Erythema, Pruritus, |
||||
BIMATOPROST, |
||||
| 226 | 25109079 |
US |
57 | 2 |
Skin irritation, Erythema, |
||||
DUPILUMAB, |
||||
| 227 | 25109088 |
GB |
2 | |
Cellulitis, Wound infection, Wound complication, Peripheral swelling, Skin tightness, Skin disorder, Erythema, Limb injury, Wound dehiscence, Alcoholism, |
||||
RISANKIZUMAB-RZAA, |
||||
| 228 | 25102449 |
JP |
63 | 2 |
Cardiac failure, Chest pain, Erythema, Feeling hot, Frequent bowel movements, Flushing, Abnormal sensation in eye, Eye pruritus, Oedema peripheral, Diarrhoea, Feeling abnormal, Malaise, Diarrhoea, Nausea, Vomiting, Diarrhoea, Hypotension, Weight increased, Oedema, Dyspnoea, Peripheral coldness, |
||||
MACITENTAN, SELEXIPAG, SELEXIPAG, SELEXIPAG, SELEXIPAG, SELEXIPAG, SELEXIPAG, SELEXIPAG, RIOCIGUAT, HYDROCORTISONE BUTYRATE, |
||||
| 229 | 25102547 |
US |
15 | 2 |
Rebound eczema, Erythema, Pruritus, |
||||
DUPILUMAB, DUPILUMAB, HYDROXYZINE, |
||||
| 230 | 25103369 |
US |
1 | |
Mental impairment, Physical disability, Erythema, |
||||
DUPILUMAB, |
||||
| 231 | 25103725 |
US |
2 | |
Erythema, Therapeutic product effect incomplete, Expired product administered, Product complaint, |
||||
| 232 | 25103974 |
CA |
||
Pilonidal disease, Post procedural infection, Condition aggravated, Mass, Erythema, Tumour exudation, Swelling, Pain, Mouth ulceration, |
||||
INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, MESALAMINE, |
||||
| 233 | 25104053 |
US |
71 | 2 |
Dizziness, Pain, Tenderness, Headache, Dry skin, Dry mouth, Erythema, Cough, Dyspnoea, Swelling face, Drug ineffective, |
||||
ABATACEPT, |
||||
| 234 | 25104169 |
IT |
38 | 2 |
Erythema, |
||||
PEMBROLIZUMAB, CARBOPLATIN, PACLITAXEL, |
||||
| 235 | 25104257 |
US |
||
Drug ineffective, Paraesthesia, Erythema, |
||||
ADAPALENE, ADAPLANE 0.1%, |
||||
| 236 | 25104877 |
69 | 2 | |
Abdominal tenderness, Skin warm, Erythema, Abdominal pain, Skin weeping, Abdominal hernia, International normalised ratio increased, Large intestine perforation, |
||||
| 237 | 25104920 |
DE |
56 | 1 |
Hypotension, Tachycardia, Obstruction, Erythema, Supraventricular tachycardia, |
||||
CEFUROXIME SODIUM, |
||||
| 238 | 25105249 |
PT |
79 | 2 |
Papule, Pruritus, Erythema, |
||||
CLOPIDOGREL, CLOPIDOGREL BISULFATE, BISOPROLOL FUMARATE, TELMISARTAN, |
||||
| 239 | 25105983 |
US |
2 | |
Skin exfoliation, Chemical burn, Erythema, Pruritus, |
||||
NORELGESTROMIN AND ETHINYL ESTRADIOL, METHYLPHENIDATE HYDROCHLORIDE, DIAZEPAM, RISPERIDONE, HYDROXYZINE, FOLIC ACID, |
||||
| 240 | 25106047 |
TR |
46 | 2 |
Cough, Erythema, Dyspnoea, Hypertension, Nausea, Hypersensitivity, |
||||
| 241 | 25106122 |
JP |
60 | 2 |
Enterobacter bacteraemia, Cytokine release syndrome, Immune effector cell-associated neurotoxicity syndrome, Neutropenia, Ecthyma, Monocyte count abnormal, Induration, Erythema, Abdominal pain, Pain, Pyrexia, |
||||
AXICABTAGENE CILOLEUCEL, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, FLUDARABINE PHOSPHATE, FLUDARABINE PHOSPHATE, |
||||
| 242 | 25106187 |
CA |
6 | 1 |
Dermatitis acneiform, Drug hypersensitivity, Erythema, Rash macular, Rash papular, |
||||
RABEPRAZOLE SODIUM, RABEPRAZOLE, LANSOPRAZOLE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OMEPRAZOLE MAGNESIUM, PANTOPRAZOLE, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, |
||||
| 243 | 25106511 |
CN |
73 | 2 |
Drug eruption, Dermatitis exfoliative, Epidermolysis bullosa, Erythema, Skin ulcer, Skin exfoliation, Pyrexia, Erythema of eyelid, Swelling of eyelid, Eye discharge, Mucosal ulceration, Off label use, |
||||
CARBAMAZEPINE, |
||||
| 244 | 25106513 |
CO |
39 | 2 |
Pyelocaliectasis, Dysgeusia, Application site discolouration, Papule, Skin exfoliation, Pain of skin, Pain, Somnolence, Treatment noncompliance, Therapy interrupted, Accidental exposure to product, Wrong technique in product usage process, Arthropathy, Osteoarthritis, Erythema, Pruritus, |
||||
MECHLORETHAMINE HYDROCHLORIDE, MECHLORETHAMINE HYDROCHLORIDE, MECHLORETHAMINE HYDROCHLORIDE, ESZOPICLONE, DULOXETINE HYDROCHLORIDE, DULOXETIN HYDROCHLORIDE, DULOXETINE, ESCITALOPRAM OXALATE, ESCITALOPRAM, QUETIAPINE FUMARATE, QUETIAPINE, SERTRALINE HYDROCHLORIDE, |
||||
| 245 | 25106628 |
56 | 2 | |
Rash, Hyponatraemia, Dehydration, Agitation, Erythema, Constipation, |
||||
IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, OLANZAPINE, VALPROIC ACID, SUVOREXANT, |
||||
| 246 | 25107023 |
FR |
15 | 2 |
Dermatitis allergic, Erythema, Eosinophilia, |
||||
AMOXICILLIN, |
||||
| 247 | 25107025 |
FR |
54 | 2 |
Erythema, Face oedema, Malaise, |
||||
AMOXICILLIN, |
||||
| 248 | 25107139 |
US |
17 | 2 |
Choking, Rebound effect, Cough, Rebound effect, Dermatitis, Skin warm, Erythema, |
||||
DUPILUMAB, |
||||
| 249 | 25107359 |
FR |
60 | 2 |
Erythema, Eosinophilia, Pyrexia, Hepatic cytolysis, |
||||
DAPTOMYCIN, CLINDAMYCIN HYDROCHLORIDE, CLINDAMYCIN HYDROCHLORIDE, CEFAZOLIN SODIUM, CEFAZOLIN, CEFAZOLIN SODIUM, CEFAZOLIN, LINEZOLID, PRAVASTATIN SODIUM, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, FOLIC ACID, PREDNISONE, RIVAROXABAN, PROGESTERONE, CLOBETASOL PROPIONATE, CLOBETASOL PROPIONATE OINTMENT USP, 0.05%, CEFEPIME HYDROCHLORIDE, CEFEPIME, PANTOPRAZOLE, OXYCODONE HYDROCHLORIDE, METHOTREXATE, METHOTREXATE SODIUM, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, |
||||
| 250 | 25107521 |
JP |
||
Erythema, Rash, Pyrexia, |
||||
PEMBROLIZUMAB, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, CISPLATIN, |
||||
| 251 | 25097543 |
US |
18 | 1 |
Pruritus, Erythema, |
||||
EMTRICITABINE AND TENOFOVIR ALAFENAMIDE, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, |
||||
| 252 | 25097668 |
IT |
68 | 2 |
Drug hypersensitivity, Erythema, Dyspnoea, Dysaesthesia pharynx, |
||||
OXALIPLATIN, |
||||
| 253 | 25097749 |
HU |
||
Dyspnoea, Erythema, Pruritus, |
||||
OCRELIZUMAB, |
||||
| 254 | 25097922 |
US |
86 | 1 |
Erythema, Dermatitis allergic, |
||||
LENALIDOMIDE, |
||||
| 255 | 25098169 |
US |
78 | 2 |
Eczema, Pain of skin, Pruritus, Erythema, Rash vesicular, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 256 | 25098203 |
CA |
62 | |
Cough, Erythema, Breath sounds abnormal, Bronchial obstruction, Dyspnoea, Infection, Pyrexia, Sleep disorder due to a general medical condition, Sputum discoloured, Temperature intolerance, Wheezing, Product dose omission issue, Drug ineffective, |
||||
BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, MEPOLIZUMAB, OMALIZUMAB, ALBUTEROL SULFATE, PREDNISONE, |
||||
| 257 | 25098264 |
AU |
||
Blister, Erythema, |
||||
PREGABALIN, |
||||
| 258 | 25098432 |
FR |
15 | 2 |
Dermatitis allergic, Eosinophilia, Erythema, |
||||
AMOXICILLIN, |
||||
| 259 | 25098950 |
US |
66 | 1 |
Diarrhoea, Eczema, Erythema, Pruritus, Skin fissures, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 260 | 25099220 |
US |
1 | |
Eczema, Erythema, Therapeutic response shortened, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 261 | 25099287 |
US |
57 | 2 |
Erythema, |
||||
DUPILUMAB, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, BRIVARACETAM, ZONISAMIDE, AZELAIC ACID, SERTRALINE, HYDROCHLOROTHIAZIDE, LISINOPRIL, |
||||
| 262 | 25099493 |
US |
72 | 2 |
Erythema, Skin reaction, |
||||
INSULIN GLARGINE, |
||||
| 263 | 25099615 |
US |
1 | |
Rebound eczema, Erythema, Rash, Pruritus, |
||||
DUPILUMAB, DUPILUMAB, RUXOLITINIB, |
||||
| 264 | 25099707 |
FR |
72 | 2 |
Erythema, |
||||
PACLITAXEL, CARBOPLATIN, CETUXIMAB, |
||||
| 265 | 25100044 |
CN |
45 | 1 |
Erythema, Impetigo, Decreased appetite, Gingival swelling, Toothache, Ageusia, Vision blurred, Listless, |
||||
SUNITINIB MALATE, SUNITINIB MALATE, |
||||
| 266 | 25100477 |
US |
44 | 2 |
Pruritus, Erythema, |
||||
GADOBUTROL, |
||||
| 267 | 25100545 |
US |
75 | 1 |
Dermatitis atopic, Pruritus, Erythema, |
||||
DUPILUMAB, |
||||
| 268 | 25100761 |
US |
69 | 1 |
Erythema, Contusion, Haemorrhage, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 269 | 25100937 |
US |
||
Skin exfoliation, Eye swelling, Eye pruritus, Erythema, Dermatitis atopic, |
||||
NEMOLIZUMAB-ILTO, |
||||
| 270 | 25100979 |
US |
57 | 1 |
Eczema, Erythema, Pruritus, Intentional product misuse, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
| 271 | 25101020 |
US |
55 | 2 |
Tremor, Hot flush, Erythema, Migraine, |
||||
EPTINEZUMAB-JJMR, |
||||
| 272 | 25101126 |
IT |
54 | 1 |
Pruritus, Erythema, Conjunctival hyperaemia, Dyspnoea, Oxygen saturation decreased, |
||||
NIVOLUMAB, OXALIPLATIN, |
||||
| 273 | 25101193 |
US |
||
Skin exfoliation, Dry skin, Erythema, Eczema, Eczema nummular, |
||||
NEMOLIZUMAB-ILTO, |
||||
| 274 | 25101197 |
US |
2 | |
Rash, Erythema, Eye swelling, Pruritus, Therapy change, |
||||
LENALIDOMIDE, LENALIDOMIDE, |
||||
| 275 | 25101259 |
CA |
31 | 2 |
Skin exfoliation, Product administered at inappropriate site, Withdrawal syndrome, Pruritus, Staphylococcal skin infection, Erythema, Skin weeping, |
||||
| 276 | 25092179 |
US |
4 | 2 |
Erythema, Dry skin, Perioral dermatitis, Rash, |
||||
DUPILUMAB, |
||||
| 277 | 25092456 |
ES |
||
Palpitations, Dyspnoea, Erythema, Dizziness, |
||||
CABOTEGRAVIR, CABOTEGRAVIR, CABOTEGRAVIR, |
||||
| 278 | 25092473 |
US |
1 | |
Generalised oedema, Erythema, Pruritus, |
||||
DUPILUMAB, METHYLPREDNISOLONE, |
||||
| 279 | 25092482 |
GR |
77 | 2 |
Mouth swelling, Drug hypersensitivity, Erythema, Off label use, Pruritus, Chest discomfort, Asthma, Oropharyngeal swelling, Gingival erythema, Muscle spasms, Allergic oedema, Swelling, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, IRBESARTAN, METOPROLOL TARTRATE, |
||||
| 280 | 25092548 |
US |
83 | 2 |
Drug hypersensitivity, Cough, Erythema, Pulse absent, |
||||
METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA, METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA, |
||||
| 281 | 25092571 |
US |
2 | |
Oropharyngeal pain, Erythema, Pruritus, |
||||
TOCILIZUMAB, TOCILIZUMAB, |
||||
| 282 | 25092919 |
FR |
54 | 2 |
Erythema, Face oedema, Malaise, |
||||
AMOXICILLIN, |
||||
| 283 | 25093026 |
US |
1 | |
Erythema, |
||||
TRALOKINUMAB-LDRM, TRALOKINUMAB-LDRM, |
||||
| 284 | 25093327 |
14 | 2 | |
Eye swelling, Pruritus, Erythema, |
||||
CLINDAMYCIN AND BENZOYL PEROXIDE, |
||||
| 285 | 25093341 |
CA |
72 | 2 |
Malignant neoplasm progression, Transitional cell carcinoma metastatic, Fatigue, Dysphagia, Condition aggravated, Throat irritation, Hyperhidrosis, Pyrexia, Blood pressure fluctuation, Nausea, Diarrhoea, Oxygen saturation decreased, Constipation, Back pain, Abdominal pain, Erythema, Ear pain, Rash, Pain, Dry eye, Dry mouth, Dyspnoea, Chest pain, Vomiting, |
||||
ENFORTUMAB VEDOTIN, ENFORTUMAB VEDOTIN, ENFORTUMAB VEDOTIN, ENFORTUMAB VEDOTIN, ENFORTUMAB VEDOTIN, ENFORTUMAB VEDOTIN, ENFORTUMAB VEDOTIN, ENFORTUMAB VEDOTIN, ENFORTUMAB VEDOTIN, ENFORTUMAB VEDOTIN, BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, PEMBROLIZUMAB, CITALOPRAM, CITALOPRAM HYDROBROMIDE, PANTOPRAZOLE, |
||||
| 286 | 25093401 |
PT |
37 | 2 |
Erythema, Throat irritation, |
||||
PACLITAXEL, |
||||
| 287 | 25093998 |
US |
72 | 2 |
Psoriasis, Pain, Erythema, Pruritus, |
||||
DUPILUMAB, |
||||
| 288 | 25094040 |
PL |
||
Rash, Swelling, Pain, Erythema, |
||||
OSIMERTINIB, |
||||
| 289 | 25094102 |
US |
19 | 2 |
Haemorrhage, Erythema, Condition aggravated, Dry skin, Dry eye, Pruritus, Eye pruritus, Ocular hyperaemia, Drug ineffective, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 290 | 25094106 |
US |
16 | 1 |
Rash macular, Lip swelling, Skin exfoliation, Erythema, Skin burning sensation, Pruritus, |
||||
DUPILUMAB, PREDNISONE, HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, |
||||
| 291 | 25094190 |
ES |
74 | 1 |
Angioedema, Erythema, |
||||
PREGABALIN, HUMAN IMMUNOGLOBULIN G, |
||||
| 292 | 25094221 |
FR |
71 | 1 |
Hypertension, Pyrexia, Tachycardia, Oxygen saturation decreased, Erythema, Chills, |
||||
OXALIPLATIN, |
||||
| 293 | 25094265 |
CN |
63 | 1 |
Drug eruption, Hypersensitivity, Mouth ulceration, Oropharyngeal discomfort, Erythema, Pyrexia, Temperature intolerance, Chills, Swelling face, Skin exfoliation, Face oedema, Rash, |
||||
CARBAMAZEPINE, |
||||
| 294 | 25094346 |
JP |
40 | 2 |
Arthritis, Erythema, Pyrexia, Staphylococcus test positive, |
||||
OFATUMUMAB, |
||||
| 295 | 25094452 |
US |
70 | 1 |
Erythema, Pruritus, Skin burning sensation, Condition aggravated, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 296 | 25094491 |
JP |
32 | 2 |
Blood pressure decreased, Oxygen saturation decreased, Erythema, Anaphylactic reaction, |
||||
MEROPENEM, |
||||
| 297 | 25094718 |
MX |
50 | 1 |
Skin lesion, Product use in unapproved indication, Pruritus, Hypersensitivity, Skin swelling, Scratch, Erythema, |
||||
LENALIDOMIDE, RITUXIMAB, |
||||
| 298 | 25094791 |
US |
67 | 2 |
Illness, Flushing, Erythema, Body temperature increased, Diarrhoea, Feeling hot, |
||||
AVAPRITINIB, |
||||
| 299 | 25094954 |
TH |
79 | 1 |
Pain in extremity, Gait inability, Musculoskeletal stiffness, Fatigue, Product use issue, Hypersensitivity, Skin fissures, Dry skin, Peripheral swelling, Erythema, |
||||
REGORAFENIB, REGORAFENIB, |
||||
| 300 | 25095112 |
US |
||
Erythema, Product colour issue, Poor quality product administered, |
||||
TRETINOIN AND BENZOYL PEROXIDE, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-04-28